Author:
Palmér Sofia,Blomqvist Carl,Holmqvist Marit,Lindman Henrik,Lambe Mats,Ahlgren Johan
Abstract
Abstract
Background
Population-based cancer quality registries are of great importance for the improvement of cancer care. However, little is known about the quality of recurrence data in cancer quality registries. The aim of this study was to evaluate data quality in the regional Breast Cancer Quality Registry of Central Sweden, with emphasis on the validity of recorded information on recurrence.
Methods
Validation by re-abstraction was performed on a random sample of 800 women with primary invasive breast cancer stage I-III diagnosed between 1993 and 2010, of which 400 had at least one registered recurrence and 400 had no registered recurrence. Registry data were compared with data from medical records. Exact agreement, correlation and kappa values, sensitivity and specificity were calculated.
Results
Seven hundred forty-seven women (93%) were available for analysis. Exact agreement was high for diagnostics, tumor characteristics, surgery, and adjuvant oncological treatment (90% or more for most variables). The registry’s sensitivity was low for regional recurrence (47%), but higher for local and distant recurrence (80% and 75%), whereas specificity was overall high (≥ 95%). Combining all recurrence categories irrespective of localization improved sensitivity to 90% with a specificity of 91%. In 87% of women, the date of first recurrence according to medical records fell within ± 90 days of the date recorded in the registry.
Conclusions
While the quality of data in the regional Breast Cancer Quality Registry was generally high, data accuracy on recurrences was lower. The overall precision of identifying any recurrence, irrespective of localization, was high. However, the accuracy of classification of recurrences (local, regional or distant) was lower, with evidence of underreporting for each of the recurrence categories. Given the importance of recurrence-related outcomes in the assessment of quality of care, efforts should be made to improve the reporting of recurrences.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13:102–11. https://doi.org/10.1007/s10147-008-0762-6.
2. Armstrong BK. The role of the cancer registry in cancer control. Cancer Causes Control. 1992;3:569–79.
3. Polissar L, Feigl P, Lane WW, Glaefke G, Dahlberg S. Accuracy of basic cancer patient data: results from an extensive recoding survey. J Natl Cancer Inst. 1984;72:1007–14.
4. Liu WL, Kasl S, Flannery JT, Lindo A, Dubrow R. The accuracy of prostate cancer staging in a population-based tumor registry and its impact on the black-white stage difference (Connecticut, United States). Cancer Causes Control. 1995;6:425–30.
5. Izquierdo JN, Schoenbach VJ. The potential and limitations of data from population-based state cancer registries. Am J Public Health. 2000;90:695–8.